Sinopharm Vaccines for Non-Subsidized Program to Arrive Late April



Petir Garda Bhwana

  • Font:
  • Ukuran Font: - +
  • Shinta Widjaja Kamdani, CEO of Sintesa Group

    Shinta Widjaja Kamdani, CEO of Sintesa Group

    TEMPO.CO, JakartaSinopharm Covid-19 vaccine produced by a Chinese pharmaceutical firm was scheduled to arrive in Indonesia in the fourth week of April 2021. The vaccine will be allocated to the 'gotong-royong' vaccine program, which is vaccination held by corporations under the coordination of the Chamber of Commerce and Industry or Kadin.

    “According to Bio Farma, Sinopharm vaccines will start arriving in the fourth week of April. They have not said the price,” said Kadin Deputy Chairman for International Relations, Shinta Widjaja Kamdani, on Monday, April 19, 2021.

    The non-subsidized vaccination programs are held and paid by companies for employees and their family members so that employees do not have to pay for vaccines.

    A total of 17,386 companies, said Shinta, have registered to participate in the program through Kadin. She ensured that the companies were ready to hold vaccinations. At present, Kadin is waiting for the assurance of vaccine stocks from Bio Farma.

    “Because the vaccine provider determined by the government is Bio Farma. We from Kadin are ready to help with the implementation, so we are waiting for the vaccine,” said Shinta.

    Previously reported, Bio Farma Director Honesti Basyir said his side had secured around 35 million vaccines for the 'gotong-royong' vaccine program in early April. The vaccines to be used are Sinopharm, CanSino, and Sputnik V.

    Read: Bio Farma: 806 Health Facilities to Serve Non-subsidized COVID-19 Vaccinations